CIK 0001468748 · Non-accelerated filer<br>Smaller reporting company
Kodiak Sciences Inc.
Sign in to watch- Ticker
- KOD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 270476525
- Phone
- 650-281-0850
- Business address
- 1250 PAGE MILL RD, PALO ALTO, CA, 94304
- Former names
- Oligasis, LLC
- Open-market buys, last 90 days
- $181,327,230
- in 4 filings
- Open-market sales, last 90 days
- $2,700,322
- in 1 filing, $2.7M under 10b5-1 plans
Net +$178,626,907. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +843 | $46.50 | $39K | 973,398 |
| 2020-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +10,640 | $46.50 | $495K | 10,620,351 |
| 2020-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +3,262 | $47.72 | $156K | 976,660 |
| 2020-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +41,155 | $47.72 | $2.0M | 10,661,506 |
| 2020-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +60 | $47.82 | $3K | 976,720 |
| 2020-08-20 | BAKER BROS. ADVISORS LP Director | Purchase | +754 | $47.82 | $36K | 10,662,260 |
| 2020-08-19 | BAKER BROS. ADVISORS LP Director | Purchase | +284 | $46.99 | $13K | 972,272 |
| 2020-08-19 | BAKER BROS. ADVISORS LP Director | Purchase | +3,585 | $46.99 | $168K | 10,606,135 |
| 2020-07-20 | EHRLICH JASON See Remarks | Option exercise | +6,950 | $10.29 | $72K | 40,934 |
| 2020-07-20 | EHRLICH JASON See Remarks | Sale | −1,474 | $49.77 | $73K | 39,460 |
| 2020-07-20 | EHRLICH JASON See Remarks | Sale | −5,100 | $50.57 | $258K | 34,360 |
| 2020-07-20 | EHRLICH JASON See Remarks | Sale | −376 | $51.19 | $19K | 33,984 |
| 2020-07-20 | EHRLICH JASON See Remarks | Option exercise · Stock Option (Right to Buy) | −6,950 | 386,475 | ||
| 2020-07-02 | EHRLICH JASON See Remarks | Option exercise | +2,700 | $10.29 | $28K | 33,984 |
| 2020-07-02 | EHRLICH JASON See Remarks | Option exercise · Stock Option (Right to Buy) | +2,700 | 393,425 | ||
| 2020-06-30 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +7,106 | 7,106 | ||
| 2020-06-30 | Yang Taiyin Director | Grant or award · Stock Option (Right to Buy) | +5,417 | 5,417 | ||
| 2020-06-30 | PROFUSEK ROBERT Director | Grant or award · Stock Option (Right to Buy) | +7,106 | 7,106 | ||
| 2020-06-30 | Levy Richard S Director | Grant or award · Stock Option (Right to Buy) | +7,106 | 7,106 | ||
| 2020-06-30 | Dahiyat Bassil I Director | Grant or award · Stock Option (Right to Buy) | +7,106 | 7,106 |
Page 29 of 37 · 722 trades